There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...

We rate McKesson as a 'Strong Buy' with focus on GLP-1 meds, oncology network, and strong Q2 results driving future growth.

People are more likely to develop type 2 diabetes if they are: Experts with UW Health say it is important to remember the ...

Moderation and self-control used to serve as WeightWatchers' main talking points, but the company has since transitioned to ...

USA: A recent study published in Diabetes Technology & Therapeutics has highlighted the advantages of integrating FreeStyle ...